SCHEMBL25218005

SCHEMBL25218005

O=C(O)C1COCC(Nc2ncc(C(F)(F)F)c(OC3COC3)n2)C1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 5/20 0.41
KDR P35968 1/20 0.41
HSD11B1 P28845 4/20 0.41
MAPK3 P27361 3/20 0.40
ULK1 O75385 1/20 0.39
CDK1 P06493 1/20 0.38
PTK2 Q05397 1/20 0.37
ATXN2 Q99700 1/20 0.37
LRRK2 Q5S007 4/20 0.37
MAPK1 P28482 1/20 0.36
CCNE1 P24864 4/20 0.35
CCNK O75909 3/20 0.35
CDK12 Q9NYV4 3/20 0.35
CDK7 P50613 2/20 0.35
CCNH P51946 2/20 0.35
MNAT1 P51948 2/20 0.35
CCNT1 O60563 2/20 0.35
CDK9 P50750 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30397931 1.00 CDK2 (0.41) CDK2KDRHSD11B1MAPK3ULK1
SCHEMBL30397298 0.90 CDK2 (0.40) CDK2KDRHSD11B1MAPK3ULK1
SCHEMBL25224397 0.90 CDK2 (0.40) CDK2KDRHSD11B1MAPK3ULK1
SCHEMBL22998319 0.83 ULK1 (0.44) CDK2KDRHSD11B1MAPK3ULK1
SCHEMBL25209416 0.82 GRM5 (0.38) CDK2KDRMAPK3ULK1PTK2
SCHEMBL30397703 0.82 GRM5 (0.38) CDK2KDRMAPK3ULK1PTK2
SCHEMBL30397992 0.80 MAPK3 (0.46) CDK2KDRHSD11B1MAPK3ULK1
SCHEMBL30397130 0.80 MAPK3 (0.46) CDK2KDRHSD11B1MAPK3ULK1
SCHEMBL25522696 0.80 ULK1 (0.55) CDK2KDRMAPK3ULK1CDK1
SCHEMBL28486909 0.79 ULK1 (0.42) CDK2KDRMAPK3ULK1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed